

Can't find Menopur? Learn about alternatives like Gonal-F, Follistim, and Pergoveris that your doctor may recommend for your fertility treatment.
Getting a call from your pharmacy saying they can't fill your Menopur prescription is stressful — especially when you're counting down the days to your IVF cycle start. But before you panic, know this: there are effective alternatives your reproductive endocrinologist can consider.
In this guide, we'll explain what Menopur does, how it works, and walk you through the most common alternative medications that may be used in its place.
Menopur is the brand name for Menotropins, a fertility injectable made by Ferring Pharmaceuticals. It contains two key reproductive hormones:
These hormones work together to prepare your ovaries to produce multiple mature eggs, which is essential for IVF and other assisted reproductive technologies. To learn more, check out our detailed explanation of how Menopur works.
Menopur is derived from the urine of postmenopausal women, which naturally contains high levels of FSH and LH. After purification, these hormones are formulated into an injectable medication. When injected subcutaneously (under the skin), they mimic the signals your brain normally sends to your ovaries — but at higher levels, encouraging the growth of many follicles rather than the single one your body would usually produce each month.
Your doctor monitors your response with blood tests (estradiol levels) and ultrasounds to track follicle growth, adjusting your dose as needed. A typical course lasts 5 to 12 days.
If you can't get Menopur, your doctor has several proven options. Here are the most commonly used alternatives:
Gonal-F is one of the most widely prescribed fertility medications in the world. It's a recombinant (lab-made) form of FSH, meaning it's produced using genetic engineering rather than derived from human urine.
Follistim AQ is another recombinant FSH product, very similar to Gonal-F in how it works.
Pergoveris is the closest pharmacologic match to Menopur among recombinant options. It combines both FSH and LH in a single injection — just like Menopur does, but made through recombinant technology instead of urinary extraction.
Many reproductive endocrinologists create a "DIY Menopur" by combining a recombinant FSH product (Gonal-F or Follistim) with low-dose hCG to provide LH-like activity. Human chorionic gonadotropin (hCG) binds to the same receptor as LH and can effectively replace Menopur's LH component.
All of these alternatives require a prescription and should only be used under the direct guidance of your reproductive endocrinologist. Switching fertility medications can affect your hormone levels and follicle response, so your doctor will need to adjust your monitoring plan accordingly.
Never use leftover medication from a friend's cycle, purchase fertility drugs from unverified sources, or attempt to modify your protocol without medical supervision.
If you'd prefer to stay on Menopur, don't give up yet. Use Medfinder to check which pharmacies near you have it in stock. You can also read our tips on how to find Menopur in stock. And for the latest on supply, see our Menopur shortage update for 2026.
Not being able to fill your Menopur prescription is frustrating, but it doesn't mean your fertility treatment has to be delayed. Gonal-F, Follistim AQ, and Pergoveris are all well-established alternatives, and your doctor can help you find the right option for your specific protocol. The most important thing is to communicate with your care team as soon as you know there's a problem — the sooner they know, the more time they have to adjust your plan.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.